通達集團(00698.HK)恢復建議分拆通達創智A股上市 股價漲近17%撲50天線
通達集團(00698.HK)恢復建議分拆通達創智A股上市,該股今早漲近16.7%半日高收0.315元,挑戰50天線(0.32元),半日成交急增至7,645萬股。
通達集團公布,由於近期市況好轉,決定恢復建議分拆通達創智,並計劃於10月提交建議A股上市之申請。聯交所已確認公司可繼續進行建議分拆。
通達創智從事為歐美大型品牌生產家庭耐用品、家用工具、體育用品及健康護理用品。預期分拆將涉及公開發售及/或配售新A股,股數擬不超過經擴大股本的25%,集資總額介乎6.6-7.7億人民幣。完成後,公司於通達創智持股將由目前90%攤薄至不少於67.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.